A study on DNA methylation modifying natural compounds identified EGCG for induction of IFI16 gene expression related to the innate immune response in cancer cells

Khan,Mohammad Imran; Nur,Suza Mohammad; Abdulaal,Wesam H.

doi:10.3892/ol.2022.13339

A study on DNA methylation modifying natural compounds identified EGCG for induction of IFI16 gene expression related to the innate immune response in cancer cells

Authors:
- Mohammad Imran Khan
- Suza Mohammad Nur
- Wesam H. Abdulaal
View Affiliations

Affiliations: Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Published online on: May 19, 2022 https://doi.org/10.3892/ol.2022.13339
Article Number: 218
Copyright: © Khan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Innate immune sensor IFN‑induced protein 16 (IFI16) exhibits anti‑inflammatory effects via IFNβ and IFN‑stimulated gene (ISG)15 induction in cancer cells. Epigallocatechin gallate (EGCG) is a potent natural DNA methyltransferase inhibitor (DNMTi). Previous studies revealed that conventional DNMTis, such as 5‑azacytidine (5‑aza‑dc), induce IFI16 expression and EGCG decreases DNMT mRNA expression and global methylation (5mC) level via promoter demethylation of tumor suppressor genes in cancer cell lines. To the best of our knowledge, however, EGCG‑mediated IFI16 promoter methylation status has been overlooked. Here, initial screening was performed to determine IFI16 expression and its correlation with DNMTs in cancer cell lines from various databases. Following treatment of breast cancer cell lines with 5‑aza‑dc, vitamin C and EGCG, expression levels of IFI16 and its downstream transcription targets IFNβ1 and ISG15 were assessed using RT-qPCR, and the 5mC level was assessed using ELISA. In silico molecular docking simulation was performed for all DNMTs to predict the mode of ligands binding with proteins. Finally, promoter methylation level in IFI16 gene was assessed following EGCG treatment. EGCG treatment induced IFI16 expression, interacted with certain amino acids residues in DNMT proteins and decreased 5mC level and promoter methylation of IFI16. The present results may provide a basis for targeting IFI16 expression as a therapeutic option in breast cancer cell lines.

View Figures

View References

1	Choubey D and Panchanathan R: IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases. Ageing Res Rev. 28:27–36. 2016. View Article : Google Scholar : PubMed/NCBI
2	Ouchi M and Ouchi T: Role of IFI16 in DNA damage and checkpoint. Front Biosci. 13:236–239. 2008. View Article : Google Scholar
3	Duan X, Ponomareva L, Veeranki S, Panchanathan R, Dickerson E and Choubey D: Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts. Mol Cancer Res. 9:589–602. 2011. View Article : Google Scholar : PubMed/NCBI
4	Stratmann SA, Morrone SR, van Oijen AM and Sohn J: The innate immune sensor IFI16 recognizes foreign DNA in the nucleus by scanning along the duplex. ELife. 4:e117212015. View Article : Google Scholar : PubMed/NCBI
5	Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, et al: IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 11:997–1004. 2010. View Article : Google Scholar
6	Orzalli MH, DeLuca NA and Knipe DM: Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci USA. 109:E3008–E3017. 2012. View Article : Google Scholar : PubMed/NCBI
7	Choubey D, Deka R and Ho SM: Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. Front Biosci. 13:598–608. 2008. View Article : Google Scholar
8	Johnstone RW and Trapani JA: Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol. 19:5833–5838. 1999. View Article : Google Scholar
9	Ludlow LE, Johnstone RW and Clarke CJ: The HIN-200 family: More than interferon-inducible genes? Exp Cell Res. 308:1–17. 2005. View Article : Google Scholar : PubMed/NCBI
10	Choubey D, Duan X, Dickerson E, Ponomareva L, Panchanathan R, Shen H and Srivastava R: Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: Role in inflammation and autoimmunity. J Interferon Cytokine Res. 30:371–380. 2010. View Article : Google Scholar : PubMed/NCBI
11	Veeranki S and Choubey D: Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: Regulation of subcellular localization. Mol Immunol. 49:567–571. 2012. View Article : Google Scholar
12	Decout A, Katz JD, Venkatraman S and Ablasser A: The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 21:548–569. 2021. View Article : Google Scholar
13	Bhat N and Fitzgerald KA: Recognition of cytosolic DNA by cGAS and other STING-dependent sensors. Eur J Immunol. 44:634–640. 2014. View Article : Google Scholar
14	Thompson MR, Sharma S, Atianand M, Jensen SB, Carpenter S, Knipe DM, Fitzgerald KA and Kurt-Jones EA: Interferon γ-inducible Protein (IFI) 16 transcriptionally regulates Type I interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem. 289:235682014. View Article : Google Scholar : PubMed/NCBI
15	Kopitar-Jerala N: The role of interferons in inflammation and inflammasome activation. Front Immunol. 8:8732017. View Article : Google Scholar
16	Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S and Sekine Y: Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat. 13:690–700. 2006. View Article : Google Scholar
17	Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, Block TM and Guo JT: Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol. 82:1665–1678. 2008. View Article : Google Scholar
18	Schoggins JW and Rice CM: Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 1:5192011. View Article : Google Scholar
19	Xin H, Curry J, Johnstone RW, Nickoloff BJ and Choubey D: Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene. 22:4831–4840. 2003. View Article : Google Scholar : PubMed/NCBI
20	Duan X, Ponomareva L, Veeranki S and Choubey D: IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway. PLoS One. 6:e1953220122 View Article : Google Scholar : PubMed/NCBI
21	Lin W, Zhao Z, Ni Z, Zhao Y, Du W and Chen S: IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome. Cell Prolif. 50:e123922017. View Article : Google Scholar
22	Kondo Y, Nagai K, Nakahata S, Saito Y, Ichikawa T, Suekane A, Taki T, Iwakawa R, Enari M, Taniwaki M, et al: Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation. Cancer Sci. 103:782–790. 2012. View Article : Google Scholar
23	Yu B, Zheng X, Sun Z, Cao P, Zhang J and Wang W: IFI16 can be used as a biomarker for diagnosis of renal cell carcinoma and prediction of patient survival. Front Genet. 12:5999522012. View Article : Google Scholar
24	Chen JX, Cheng CS, Gao HF, Chen ZJ, Lv LL, Xu JY, Shen XH, Xie J and Zheng L: Overexpression of interferon-inducible Protein 16 promotes progression of human pancreatic adenocarcinoma through interleukin-1β-induced tumor-associated macrophage infiltration in the tumor microenvironment. Front Cell Dev Biol. 9:6407862021. View Article : Google Scholar
25	Intra J and Kuo SM: Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal Caco-2 cells. Chem Biol Interact. 169:91–99. 2007. View Article : Google Scholar
26	Cione E, La Torre C, Cannataro R, Caroleo MC, Plastina P and Gallelli L: Quercetin, epigallocatechin gallate, curcumin, and resveratrol: From dietary sources to human MicroRNA modulation. Molecules. 25:632019. View Article : Google Scholar
27	Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W and Yang CS: Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63:7563–7570. 2003.PubMed/NCBI
28	Beetch M, Harandi-Zadeh S, Shen K, Lubecka K, Kitts DD, O'Hagan HM and Stefanska B: Dietary antioxidants remodel DNA methylation patterns in chronic disease. Br J Pharmacol. 177:1382–1408. 2020. View Article : Google Scholar
29	Kuo CL, Chen TS, Liou SY and Hsieh CC: Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model. Immunopharmacol Immunotoxicol. 36:364–370. 2014. View Article : Google Scholar
30	Nance Cl, Mata M, McMullen A, McMullen A and Shearer WT: Regulation of innate immune recognition of viral infection by epigallocatechin gallate. J Allergy Clin Immunol. 133:AB2462014. View Article : Google Scholar
31	Liu M, Ohtani H, Zhou W, Ørskov AD, Charlet J, Zhang YW, Shen H, Baylin SB, Liang G, Grønbæk K and Jones PA: Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine. Proc Natl Acad Sci USA. 113:10238–10244. 2016. View Article : Google Scholar : PubMed/NCBI
32	Li T, Diner BA, Chen J and Cristea IM: Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci. 109:10558–10563. 2012. View Article : Google Scholar
33	Alimirah F, Chen J, Davis FJ and Choubey D: IFI16 in human prostate cancer. Mol Cancer Res. 5:251–259. 2007. View Article : Google Scholar : PubMed/NCBI
34	Takeshima H, Yoda Y, Wakabayashi M, Hattori N, Yamashita S and Ushijima T: Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level. Clin Epigenetics. 12:1422020. View Article : Google Scholar : PubMed/NCBI
35	Morris J, Moseley VR, Cabang AB, Coleman K, Wei W, Garrett-Mayer E and Wargovich MJ: Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells. Oncotarget. 7:35313–35326. 2016. View Article : Google Scholar
36	Huang CY, Han Z, Li X, Xie HH and Zhu SS: Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer. Oncol Lett. 14:3623–3627. 2017. View Article : Google Scholar
37	Moradzadeh M, Hosseini A, Erfanian S and Rezaei H: Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. Pharmacol Rep. 69:924–928. 2017. View Article : Google Scholar : PubMed/NCBI
38	Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, Han H, Liang G, Jones PA, Pugh TJ, et al: DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell. 162:961–973. 2015. View Article : Google Scholar
39	Rialdi A, Campisi L, Zhao N, Lagda AC, Pietzsch C, Ho JSY, Martinez-Gil L, Fenouil R, Chen X, Edwards M, et al: Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 352:aad79932016. View Article : Google Scholar : PubMed/NCBI
40	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
41	Islam MR, Awal MA, Khames A, Abourehab MAS, Samad A, Hassan WMI, Alam R, Osman OI, Nur SM, Molla MHR, et al: Computational identification of druggable bioactive compounds from catharanthus roseus and avicennia marina against colorectal cancer by targeting thymidylate synthase. Mol. 27:20892022. View Article : Google Scholar
42	Ikwu FA, Shallangwa GA, Mamza PA and Uzairu A: In silico studies of piperazine derivatives as potent anti-proliferative agents against PC-3 prostate cancer cell lines. Heliyon. 6:e032732020. View Article : Google Scholar : PubMed/NCBI
43	Zevini A, Olagnier D and Hiscott J: Crosstalk between cytoplasmic RIG-I and STING sensing pathways. Trends Immunol. 38:194–205. 2017. View Article : Google Scholar
44	Nur SM, Rath S, Ahmad V, Ahmad A, Ateeq B and Khan MI: Nutritive vitamins as epidrugs. Crit Rev Food Sci Nutr. 61:1–13. 2021. View Article : Google Scholar : PubMed/NCBI
45	de Ruyck J, Brysbaert G, Blossey R and Lensink MF: Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem. 9:1–11. 2016.PubMed/NCBI
46	Won JL, Shim JY and Zhu BT: Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol. 68:1018–1030. 2005. View Article : Google Scholar
47	Okude H, Ori D and Kawai T: Signaling through nucleic acid sensors and their roles in inflammatory diseases. Front Immunol. 11:6258332021. View Article : Google Scholar
48	Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, et al: Erratum: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell. 152:974–986. 2015. View Article : Google Scholar
49	Sheng J, Shi W, Guo H, Long W, Wang Y, Qi J, Liu J and Xu Y: The inhibitory effect of (−)-Epigallocatechin-3-Gallate on breast cancer progression via reducing SCUBE2 methylation and DNMT activity. Molecules. 24:28992019. View Article : Google Scholar
50	Nandakumar V, Vaid M and Katiyar SK: (−)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p 16 INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis. 32:537–544. 2011. View Article : Google Scholar : PubMed/NCBI
51	Blaschke K, Ebata KT, Karimi MM, Zepeda-Martínez JA, Goyal P, Mahapatra S, Tam A, Laird DJ, Hirst M, Rao A, et al: Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 500:222–226. 2013. View Article : Google Scholar : PubMed/NCBI
52	Rajavelu A, Lungu C, Emperle M, Dukatz M, Bröhm A, Broche J, Hanelt I, Parsa E, Schiffers S, Karnik R, et al: Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2. Nucleic Acids Res. 46:9044–9056. 2018. View Article : Google Scholar : PubMed/NCBI
53	Bostick M, Jong KK, Estève PO, Clark A, Pradhan S and Jacobsen SE: UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 317:1760–1764. 2007. View Article : Google Scholar : PubMed/NCBI
54	Khan MA, Hussain A, Sundaram MK, Alalami U, Gunasekera D, Ramesh L, Hamza A and Quraishi U: (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Oncol Rep. 33:1976–1984. 2015. View Article : Google Scholar : PubMed/NCBI
55	Yiannakopoulou EC: Targeting DNA methylation with green tea catechins. Pharmacology. 95:111–116. 2015. View Article : Google Scholar : PubMed/NCBI
56	Alivand MR, Najafi S, Esmaeili S, Rahmanpour D, Zhaleh H and Rahmati Y: Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma. Cancer Genet. 258–259. 135–150. 2021.